期刊文献+

外周动脉疾病194例诊治体会

Experiences in the diagnosis and treatment of 194 cases of peripheral arterial disease
下载PDF
导出
摘要 目的总结外周动脉疾病(peripheral arterial disease,PAD)的诊治体会。方法分析2007年8月至2011年8月收治的PAD连续病例共194例,手术治疗主要采用血管重建术,包括经皮腔内血管成型(percutanoustransluminal angioplasty,PTA)/支架成型和旁路手术,术后辅以抗血小板等综合治疗。对于术后病变仍继续进展,或广泛感染虽经清创和全身应用抗生素仍无法控制感染并危及生命者,则行截肢术。结果本组病例中181例施行血管重建术,其中136例通过腔内技术(PTA/支架成型)实现。最终截肢共18例,住院期间死亡6例。最终治疗有效率达82%。相比较于非糖尿病患者,合并糖尿病者间歇性跛行发生率较低,而溃疡、坏疽和感染的比率较高。结论血管重建是治疗PAD的基本方法 ,通过明确诊断及适当治疗,多数PAD患者可通过血管重建取得较好的疗效,并且对于多数病例,血管重建可通过腔内技术实现。 Objective To review the experiences in diagnosis and treatment of peripheral arterial disease (PAD). Methods Clinical data of 194 hospitalized patients with PAD during admitted from August 2007 to August 2011 were retrospectively reviewed. Endovascular revascularization procedures were performed with percutanous transluminal angioplasty (PTA) by ballooning and/or stenting, or open surgical bypass. For patients ineligible for revascularization who had diffuse gangrene and uncontrollable infection after extensive debridement and vigorous antibiotic use amputation was performed as the last measure. Results Revascularization was achieved in 181 cases, with 136 of them by endovascular methods; 18 of all the cases ultimately subjected to amputation and 6 died during the hospitalization. Alleviation of the symptoms was achieved in most of the cases with an overall success rate of 82%. Patients complicated with diabetes had a lower rate of intermittent claudication yet a higher rate of ulcer, gangrene and infection. Conclusion The most fundamental approach in treating PAD is revasculadzation, which can be achieved in most cases by endovascular techniques.
出处 《同济大学学报(医学版)》 CAS 2013年第1期96-99,共4页 Journal of Tongji University(Medical Science)
关键词 外周动脉疾病 诊断 治疗 血管重建 peripheral arterial disease diagnosis treatment revascularization
  • 相关文献

参考文献7

  • 1刘冰,张廷久,金春.水化疗法预防造影剂肾病150例临床分析[J].中国临床研究,2011,24(5):411-412. 被引量:6
  • 2Duvall WL, Vorchheimer DA. Multi-bed vascular disease and atherothrombosis, scope of the problem [J]. J Thromb Thrombolysis, 2004, 17( 1 ) : 51 -61.
  • 3Adler AI, Stevens RJ, Neil A, et al. UKPDS 59: Hypergycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes [J]. Diabetes Care, 2002,25(5): 894-899.
  • 4Lockhart C J, Hamilton PK, McVeigh KA, et al. A cardiologist view of vascular disease in diabetes [J]. Diabetes Obes Metab, 2008, 10(4): 279-292.
  • 5American Diabetes Association. Peripheral arterial disease in people with diabetes [J]. Diabetes Care, 2003, 26(12): 3333-3341.
  • 6Muntner P, Wildman RP, Reynolds K, et al. Relationship between HbAlc level and peripheral arterial disease [ J ]. Diabetes Care, 2005,28 ( 8 ) : 1981 - 1987.
  • 7Hong MS, Beck AW, Nelson PR. Emerging national trends in the management and outcomes of lower extremity peripheral arterial disease [ J ]. Ann Vasc Surg, 2011,25(1): 44-54.

二级参考文献3

  • 1De Broe ME, Porter GA, Bennett WM, et al. Clinical nephrotoxins: renal injury from drugs and chcmicals[M]. Dordrecht: Kluwer Aeademic Publications,2003 : 587.
  • 2Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of cantrast nephrotoxieity [J]. Nephron Clin Praet, 2003,93 ( 1 ) : 29 - 34.
  • 3McCullough PA, Soman SS. Contrast-induced nephropathy[J]. Crit Care Clin,2005,21 (2) :261 - 280.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部